In this GEN webinar, experts from Perceptive Imaging and Flywheel explore how imaging data access issues slow decision-making and increase risks for both biopharma and CROs.

A new study suggests that the immune checkpoint inhibitor, durvalumab, may offer new treatment options for patients living ...

You’ve done Champagne toasts and countdown kisses, but have you tried eating grapes on New Year’s Eve for good luck? In recent years, the tradition—which involves some iteration of eating exactly 12 ...

Commissioner Marty Makary said that the FDA will soon start requiring only one pivotal trial, instead of two, for companies seeking approval for new drugs. The FDA will begin asking for only one ...

The FDA has authorized a Phase 3 trial of PrimeC, an experimental oral therapy for ALS. In a prior Phase 2b study, PrimeC slowed ALS progression by 37.4% and improved survival by 43% in key patient ...

Milbank LLP is paying associates up to $115,000 in year-end bonuses, matching its Big Law competitors in total extra compensation, the firm announced Monday. The annual bonuses, paid on a ...

"Find a mentor you trust—someone ethical, talented, and invested in your success. We all know you don’t learn how to be a lawyer in law school; you learn it from working alongside people who know how ...

If you appreciate the Mercury's interesting and useful news & culture reporting, consider making a small monthly contribution to support our editorial team. Your donation is tax-deductible. You can ...

While the costs of attending a four-year university continue to rise, two-year colleges can still provide a valuable postsecondary education and career prospects. A new report by Stacker analyzed ...

Trial management has become one of the most decisive factors in determining whether diagnostic and medtech innovations make it to market successfully. For companies developing in vitro diagnostics and ...